Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death

Cancer Discovery(2023)10.1158/2159-8290.cd-22-0882Source: DataRank Database

Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death is a research paper published in Cancer Discovery (2023). On theSindex it has a DataRank of 0. It has been cited 21 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access21 citations

Download PDF

Cite:

Linked data & code

gen nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 2.35)OA: greenTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (3)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Tatsuya Kawase ORCID,An Xu ORCID,Asja Guzman ORCID,Aleksandar Obradović ORCID,Ana María Low-Calle ORCID

Live enrichment

PubMed:37067901 PMC:PMC10287063 OpenAlex:https://openalex.org/W4366083866

National Cancer Institute

Grant: R35CA220526

National Cancer Institute

Grant: R01CA246130

National Cancer Institute

Grant: R15CA213426

Cancer Prevention and Research Institute of Texas

Grant: RP210045

NCI NIH HHS

Grant: P01 CA087497

NCI NIH HHS

Grant: P30 CA042014

FWCI

2.35

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

green

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10287063/pdf/nihms-1883043.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-22-0882/3321564/cd-22-0882.pdf

publisherhttps://aacrjournals.org/cancerdiscovery/article-pdf/13/5/1250/3328629/1250.pdf

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10287063

Fields of Study

Cancer-related Molecular PathwaysCell death mechanisms and regulationCancer, Hypoxia, and MetabolismHumansLi-Fraumeni SyndromeTranscriptional ActivationTumor Suppressor Protein p53ApoptosisMitochondria

MeSH Terms

HumansMitochondriaTranscriptional ActivationTumor Suppressor Protein p53Li-Fraumeni SyndromeApoptosis

Keywords

TransactivationMutantBiologyCarcinogenesisWild typeProgrammed cell deathCancer researchCell biologyCancer cellSuppressorGeneTranscription factorCancerApoptosisGenetics

Sustainable Development Goals

SDG 0: Good health and well-being

Li–Fraumeni Syndrome–Associated Dimer-Forming Mutant p53 Promotes Transactivation-Independent Mitochondrial Cell Death

FAIR Checklist

Authors (16)

Funding (6 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)